[PHAS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -11.31%
YoY- -26.97%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 208 117 158 335 10,338 0 0 -
PBT -16,665 -11,141 86,232 -31,924 -27,079 -27,358 -30,375 -33.05%
Tax 116 148 -1,598 -3,126 1,600 -1,426 -4,071 -
NP -16,781 -11,289 87,830 -31,924 -28,679 -27,358 -30,375 -32.74%
Tax Rate - - 1.85% - - - - -
Total Cost 16,989 11,406 -87,672 32,259 39,017 27,358 30,375 -32.18%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -8,067.79 -9,648.72 55,588.56 -9,529.55 -277.41 0.00 -9,492,187,500,000,000.00 -99.99%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.34 -0.23 1.82 -0.66 -0.60 -0.87 -1.03 -52.33%
EPS Diluted -0.34 -0.23 1.82 -0.66 -0.60 -0.87 -1.03 -52.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.